Solid Biosciences Share Price Today
(NASDAQ: SLDB)

Name: Solid Biosciences Share Price Today (NASDAQ: SLDB) - Solid Biosciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Solid Biosciences share price is $2.88 & ₹251.78 as on 10 Feb 2025, 20.00 hrs IST

$2.88

▲

-0.25

(-7.99%)

Market is closed - opens 8 PM, 10 Feb 2025

View live Solid Biosciences share price in Dollar and Rupees. Guide to invest in Solid Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Solid Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Solid Biosciences share price movements

Today's Low: $2.88
Today's High: $3.18
$2.88
0.0%
Downside
Day's Volatility :9.46%
Upside
9.46%
52 Weeks Low: $2.88
52 Weeks High: $15.05
$2.88
0.0%
Downside
52 Weeks Volatility :80.86%
Upside
80.86%

Solid Biosciences (SLDB) Returns

Period	Solid Biosciences Inc	Russel 2000	Index (Russel 2000)
3 Months	-51.92%	0.0%	0.0%
6 Months	-59.78%	0.0%	0.0%
1 Year	-64.31%	0.0%	0.0%
3 Years	-82.39%	-13.8%	-13.8%

Solid Biosciences (SLDB) Key Statistics

in dollars & INR

Previous Close	$2.88
Open	$3.13
Today's High	$3.68
Today's Low	$2.88
Market Capitalization	$125.1M
Today's Volume	$765.4K
52 Week High	$15.05
52 Week Low	$2.88
Revenue TTM	$0.0
EBITDA	$-109.9M
Earnings Per Share (EPS)	$-2.8
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-65.79%

How to invest in Solid Biosciences Stock (SLDB) from India?

It is very easy for Indian residents to invest directly in Solid Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Solid Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Solid Biosciences or SLDB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Solid Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Solid Biosciences shares which would translate to 0.304 fractional shares of Solid Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Solid Biosciences, in just a few clicks!

Returns in Solid Biosciences (SLDB) for Indian investors in Rupees

The Solid Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Solid Biosciences investment value today

Current value as on today

₹41,019

Returns

₹58,981

(-58.98%)

Returns from Solid Biosciences Stock

₹64,312 (-64.31%)

Dollar Returns

₹5,331 (+5.33%)

Indian investors sentiment towards Solid Biosciences (SLDB)

-37%

Period: Jan 10, 2025 to Feb 9, 2025. Change in 30 Days versus previous period

Search interest for Solid Biosciences Stock from India on INDmoney has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Solid Biosciences

Perceptive Advisors LLC
17.29%
RA Capital Management, LLC
10.84%
Bain Capital Life Sciences Investors, LLC
10.10%
Vestal Point Capital LP
7.01%
Siren, L.L.C.
6.88%
Adage Capital Partners Gp LLC
4.39%

Analyst Recommendation on Solid Biosciences

Buy

80%Buy

20%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Solid Biosciences(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Solid Biosciences Stock (SLDB)

What analysts predicted

Upside of 486.81%

Target:

$16.90

Current:

$2.88

Insights on Solid Biosciences Stock (Ticker Symbol: SLDB)

Price Movement
In the last 7 days, SLDB stock has moved down by -8.6%
SLDB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.4% return, outperforming this stock by 125.4%
SLDB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 83.1% return, outperforming this stock by 166.4%

Solid Biosciences Technicals Summary

Sell

Neutral

Buy

Solid Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Solid Biosciences (SLDB) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Solid Biosciences Inc	-12.99%	-59.78%	-64.31%	-82.39%	-94.04%
Biontech Se	3.4%	45.88%	25.3%	-31.2%	297.87%
Regeneron Pharmaceuticals, Inc.	-0.96%	-36.67%	-25.03%	11.21%	74.75%
Vertex Pharmaceuticals Incorporated	13.54%	1.04%	12.14%	100.66%	93.77%
Alnylam Pharmaceuticals, Inc.	6.94%	2.22%	63.1%	83.2%	106.13%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Solid Biosciences Inc	0.15	NA	NA	-2.88	-0.66	-0.35	NA	4.29
Biontech Se	160.8	NA	0.04	-3.29	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	18.83	18.83	1.15	43.84	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.28	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Solid Biosciences Inc	Buy	$125.1M	-94.04%	0.15	0.0%
Biontech Se	Buy	$28.8B	297.87%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$78.9B	74.75%	18.83	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$123.9B	93.77%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.9B	106.13%	NA	-15.86%

About Solid Biosciences

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich's ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Organization	Solid Biosciences
Employees	88
CEO	Mr. Alexander G. Cumbo
Industry	Health Technology

Management People of Solid Biosciences

Name	Title
Mr. Ian F. Smith A.C.A., C.P.A.	Executive Chair
Mr. Alexander G. Cumbo	President, CEO & Director
Mr. Ilan Ganot	Co-founder, Strategic Advisor to the CEO & Director
Mr. Kevin Tan C.F.A.	CFO & Treasurer
Mr. David Tyronne Howton Jr., J.D.	COO, General Counsel & Secretary
Ms. Annie Ganot	Co-Founder & Head of Patient Advocacy
Mr. Paul Herzich	Chief Technology Officer
Ms. Allison Bogosian J.D.	Senior Vice President of Human Resources
Dr. Jessie Hanrahan Ph.D.	Chief Regulatory Officer
Dr. Shuli Kulak M.D.	Head of Corporate Strategy & Business Development

Important FAQs about investing in SLDB Stock from India :

What is Solid Biosciences share price today?

Solid Biosciences share price today stands at $2.88, Open: $3.13 ; Previous Close: $3.13 ; High: $3.18 ; Low: $2.88 ; 52 Week High: $15.05 ; 52 Week Low: $2.88.

The stock opens at $3.13, after a previous close of $3.13. The stock reached a daily high of $3.18 and a low of $2.88, with a 52-week high of $15.05 and a 52-week low of $2.88.

Can Indians buy Solid Biosciences shares?

Yes, Indians can invest in the Solid Biosciences (SLDB) from India.

With INDmoney, you can buy Solid Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Solid Biosciences at zero transaction cost.

How can I buy Solid Biosciences shares from India?

It is very easy to buy Solid Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Solid Biosciences (SLDB) be purchased?

Yes, you can buy fractional shares of Solid Biosciences with INDmoney app.

What are the documents required to start investing in Solid Biosciences stocks?

To start investing in Solid Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.